Voyager Therapeutics, Inc. Stock Performance

Open $2.45	Prev. Close $2.46	Circuit Range N/A
Day Range $2.38 - $2.45	Year Range $2.38 - $5.54	Volume 2,237
Average Traded $2.40

Voyager Therapeutics, Inc. Share Price Today

As of 8 October 2026, Voyager Therapeutics, Inc.'s share price is $2.41. The stock opened at $2.45, compared to its previous close of $2.46. During today's trading session, Voyager Therapeutics, Inc.'s share price traded between $2.38 and $2.45, with an average price of $2.42. Over the past 52 weeks, the stock has recorded a high of $5.54 and a low of $2.38. In terms of performance, Voyager Therapeutics, Inc.'s share price has declined by 35.39% over the last six months and is down 48.34% on a year-on-year basis.

Voyager Therapeutics, Inc. Share Price Chart

$2.38$2.45

Voyager Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap $141.45M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-1.75	Revenue (TTM) $40.37B	Return On Equity (TTM) -69.97%
Profit Margin -296.56%	Debt to Equity 0.00	Quarterly Earnings Growth YoY 12.26%

Voyager Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$13.37	$15.34	$2.59	$3.17
Net Profit	-$27.89	-$27.43	-$28.23	-$24.47
Net Profit Margin	-208.60%	-178.81%	-1089.96%	-771.92%
Income Change	N/A	1.65%	-2.92%	13.32%

Voyager Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$40.91	$250.01	$80.00	$40.37
Net Profit	-$46.41	$132.33	-$65.00	-$119.72
Net Profit Margin	-113.44%	52.93%	-81.25%	-296.56%
Income Change	N/A	385.13%	-149.12%	-84.18%

About Voyager Therapeutics, Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Voyager Therapeutics, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$2.65	$2.40	-11.13%
Sep 2026	$3.44	$2.69	-22.00%
Aug 2026	$3.08	$3.46	+14.03%
Jul 2026	$3.55	$3.03	-13.18%
Jun 2026	$3.85	$3.49	-9.82%
May 2026	$3.71	$3.87	+3.75%
Apr 2026	$3.91	$3.73	-3.49%
Mar 2026	$4.05	$3.87	-5.96%
Feb 2026	$3.91	$4.11	+5.12%
Jan 2026	$3.87	$3.91	-0.51%
Dec 2025	$3.95	$3.93	-3.79%
Nov 2025	$4.63	$4.08	-12.43%

VYGR Share Price FAQs

What is Voyager Therapeutics, Inc. share price today?

Voyager Therapeutics, Inc. share price today is $2.41 as on October 8, 2026 at 7:23 pm IST.

What is the 52 week high and 52 week low of Voyager Therapeutics, Inc. stock?

The 52 week high of Voyager Therapeutics, Inc. stock is $5.54, while the 52 week low is $2.38 as of 8 Oct '26.

What is VYGR's market capitalisation today?

VYGR market capitalisation is $141.45M as of October 8, 2026, at 7:24 pm IST.

What is VYGR's net income for the last quarter?

VYGR's net income for the last quarter is -24.47B USD.

What is the 5 year returns of VYGR?

The 5 year returns of VYGR is -33.43% as on 8 Oct '26.

What is the high & low stock price of VYGR today?

VYGR stock price hit a high of $2.45 and low of $2.38 as of 8 Oct '26.

Can I buy VYGR shares in India?

Yes. You can buy VYGR in India by opening an international trading account.